Logo

Bliss GVS Pharma Share Price

Bliss GVS Pharma (INR)160.47-6.5   (-3.9%)

Exchange ScripsBSE506197NSEBLISSGVSISININE416D01022

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Bliss GVS Pharma Performance

Market performance
Open price167.44
High168.44
Volumes702337
Prev Close160.47
Low159.01
Closing date2025-01-10
Historical performance
1 Year High185.50
3 Year High185.50
5 Year High221.00
1 Year Low92.15
3 Year Low66.10
5 Year Low66.10

Bliss GVS Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1694
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
22.26
Dividend Yield
Dividend Yield
0.31 %

Bliss GVS Pharma Investment Returns

1 Year
27.5%
3 Years
60.8%
5 Years
8%
10 Years
138.4%

Bliss GVS Pharma Technicals

IndicatorsValueSignal
5-DMA169.29Bearish
10-DMA170.58Bearish
20-DMA168.27Bearish
50-DMA150.51Bullish
100-DMA139.47Bullish
200-DMA125.35Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters77777
Foreign Investors---------------
Domestic Investors77777
Public Investors5293044730451504075143227
Government---------------

Bliss GVS Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income304178315220
Operating Profit1794135114981286
Interest691044772
Depreciation264187173172
Profit Before Tax116910615421041
Consolidated Net Profit755709150685
Adjusted EPS7717

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital105104104103
Total Reserves9490864679847881
Minority Interest358335278197
Total Non-Current Liabilities511428292452
Total Liabilities12139115351108710768
Capital Work in Progress782822224
Total Assets12139115351108710768

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities15243431355640
Cash Flow from Investing Activities-1328-78-930-470
Cash Flow from Financing Activitie-209-249-237-208
Net Cash Inflow / Outflow-1316188-38
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 22.26.
  • 3Y Stock Price CAGR of the stock is 17.3.
  • The stock has a beta of 1.1.
  • In the last financial year, the company had an EBITDA of ₹1794 Million.
  • The company generated revenue of ₹7702 Million in the previous financial year.

Bliss GVS Pharma

160.47-6.5   (-3.9%)

Investment Amount: ₹ 13195
Current Value: ₹ 16047
Performance: 21.6%
P/L: ₹ 2852
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month